Mineralys Therapeutics Inc. (MLYS)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
RA Capital Management

Peter Kolchinsky

7,692,750 $208,396,598 +6% 2.21%
2.
Samsara BioCapital

Srini Akkaraju And Michael Dybbs

5,871,018 $159,045,878 15.45%
3.
Caligan Partners

David Johnson

2,772,654 $75,111,197 5%
4. 2,232,040 $60,465,964 +31% 2.64%
5.
OrbiMed Advisors

Samuel Isaly

2,052,900 $55,613,061 +110% 1.1%
Insider Trading: Purchases See All
Insider Price Amount Total Value Remaining Holdings Date Form 4
$24.16 58,300 $1,408,528.00 5,825,521 2026-03-30 Filing
$23.67 310,700 $7,354,269.00 5,767,221 2026-03-27 Filing
$25.50 588,235 $14,999,992.50 588,235 2025-09-04 Filing
$25.50 1,176,470 $29,999,985.00 5,456,521 2025-09-04 Filing
$13.50 259,259 $3,499,996.50 8,903,838 2025-03-13 Filing
Insider Trading: Sales See All
Insider Price Amount Total Value Remaining Holdings Date Form 4
$30.30 2,171 $65,781.30 57,733 2026-07-09 Filing
$26.82 17,000 $455,895.80 614,321 2026-06-30 Filing
$25.94 58,000 $1,504,705.60 631,321 2026-06-30 Filing
$25.90 104,124 $2,696,322.22 38,400 2026-06-26 Filing
$25.00 4,584 $114,600.00 57,095 2026-06-17 Filing
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
No. Name Shares Value % Port
1. 69,580 $1,877,268 0.05%
2. 17,081 $462,724 0.13%
3. 515 $13,895 0%
4. 513 $13,841 0%
5. 319 $8,607 0%
News See All